SummaryRMgm-288
|
Successful modification | The parasite was generated by the genetic modification |
The mutant contains the following genetic modification(s) | Gene disruption |
Reference (PubMed-PMID number) |
Reference 1 (PMID number) : 19491095 |
MR4 number | |
top of page | |
Parent parasite used to introduce the genetic modification | |
Rodent Malaria Parasite | P. berghei |
Parent strain/line | P. berghei ANKA |
Name parent line/clone | Not applicable |
Other information parent line | |
top of page | |
The mutant parasite was generated by | |
Name PI/Researcher | L. Reininger, R. Tewari, O. Billker, C. Doerig |
Name Group/Department | INSERM U609 |
Name Institute | Wellcome Centre for Molecular Parasitology, Biomedical Research Centre University of Glasgow |
City | Glasgow |
Country | UK |
top of page | |
Name of the mutant parasite | |
RMgm number | RMgm-288 |
Principal name | pbnek-2- |
Alternative name | |
Standardized name | |
Is the mutant parasite cloned after genetic modification | Yes |
top of page | |
Phenotype | |
Asexual blood stage | Not different from wild type |
Gametocyte/Gamete | Not different from wild type |
Fertilization and ookinete | Male (micro) gametocytes are able to exflagellate as efficiently as wild-type parasites and female (macro)gametocytes emerge normally. Fertilisation occurs, but development is arrested at the 2N zygote stage. The defect is female gamete specific; male gametes are fertile and able to fertilize wild-type female gametes. |
Oocyst | Fertilisation of female gametes occurs, but development is arrested at the 2N zygote stage and no mature ookinetes are formed. No oocyst are formed in Anopheles stephensi mosquitoes. |
Sporozoite | Not tested |
Liver stage | Not tested |
Additional remarks phenotype | Mutant/mutation In order to investigate in more detail the stage at which the block in ookinete development occurred, the amount of DNA in individual cells was quantified using the DNA-specific fluorescent dye Hoechst 33342. In wild-type parasites, fertilisation is followed by fusion of gamete nuclei and one round of replication, increasing the zygote’s nuclear DNA content to 4C prior to meiosis. Following meiosis four sets of chromosomes are maintained within the ookinetes nucleus, making this stage tetraploid. pbnek-2- parasites appeared to undergo activation and fertilisation like wild-type parasites, but fusion of the two nuclei was impaired in a large proportion of the parasites, and the DNA content remained at just above 2C, a value consistent with the sum of the two gamete nuclei. In all round cells (i.e. female gametes, zygotes and “failed” ookinetes), the DNA content remained below the 4C value expected in normal ookinetes, indicating that the DNA replication process that precedes meiosis is affected in the mutant parasites. Analysis of the location of Nek2 in P. falciparum female gametocytes presented in this study indicates that the enzyme localises with what looks like microtubules in female gametocytes. Such a location is consistent with the established role of Neks in the regulation of microtubule dynamics. See RMgm-59, RMgm-60 for a description of the phenotype of mutants lacking expression of NEK4. In these mutants gamete formation is not affected. Fertilisation occurs, but development is arrested at 2N zygote stage, comparable to the phenotype of the mutant lacking expression of NEK2. Also in the NEK4 mutants the defect is female gamete specific; male gametes are fertile and able to fertilize wild-type female gametes. The similarity in the phenotypes caused by the loss of Pbnek-2 and Pbnek-4, and the observation that the two enzymes do not trans-phosphorylate or –activate in vitro, suggest that they function in parallel pathways involved in the same cell development process, but are not able to complement for each other. Disruption of the P. falciparum ortholog has been attempted (Solyakov et al., 2011, Nat Commun, 2:565). After transfection with a KO vector a strong PCR signal diagnostic for gene disruption was observed in transfected populations indicating that this gene is not essential for asexual proliferation. Cloning will however be required to validate this interpretation for this |
top of page | |||||||||||||||||||||||||
Details of the target gene | |||||||||||||||||||||||||
Gene Model of Rodent Parasite | PBANKA_1240700 | ||||||||||||||||||||||||
Gene Model P. falciparum ortholog | PF3D7_0525900 | ||||||||||||||||||||||||
Gene product | NIMA related kinase 2 | ||||||||||||||||||||||||
Gene product: Alternative name | NEK2 | ||||||||||||||||||||||||
top of page | |||||||||||||||||||||||||
Details of the genetic modification | |||||||||||||||||||||||||
Inducable system used | No | ||||||||||||||||||||||||
Additional remarks inducable system | |||||||||||||||||||||||||
Type of plasmid/construct used | (Linear) plasmid double cross-over | ||||||||||||||||||||||||
PlasmoGEM (Sanger) construct/vector used | No | ||||||||||||||||||||||||
Modified PlasmoGEM construct/vector used | No | ||||||||||||||||||||||||
Plasmid/construct map | |||||||||||||||||||||||||
Plasmid/construct sequence | |||||||||||||||||||||||||
Restriction sites to linearize plasmid | KpnI/SacII | ||||||||||||||||||||||||
Partial or complete disruption of the gene | Complete | ||||||||||||||||||||||||
Additional remarks partial/complete disruption | |||||||||||||||||||||||||
Selectable marker used to select the mutant parasite | tgdhfr | ||||||||||||||||||||||||
Promoter of the selectable marker | pbdhfr | ||||||||||||||||||||||||
Selection (positive) procedure | pyrimethamine | ||||||||||||||||||||||||
Selection (negative) procedure | No | ||||||||||||||||||||||||
Additional remarks genetic modification | |||||||||||||||||||||||||
Additional remarks selection procedure | |||||||||||||||||||||||||
Primer information: Primers used for amplification of the target sequences
Primer information: Primers used for amplification of the target sequences
| |||||||||||||||||||||||||
top of page |